In this era of fast-moving science, such as genomics, and the explosion in potentially paradigm-changing Big Data streams, we need to put Europe’s 500 million potential patients across 28 EU member states at the heart of this incredible revolution.

As the European discussion on personalised medicine gathers pace, the European Alliance for Personalised Medicine (EAPM) was formed in 2012 as a response to the need for a wider understanding of priorities and a more integrated approach among distinct lay and professional stakeholders. By the end of March 2017 it will have held five Presidency conferences.

On top of this, the Alliance will organise the first major European Personalised Medicine Congress will be held in Belfast from 27-30 November entitled ‘Personalising Your Health: A Global Imperative! .

All sessions of the Congress will include a keynote speech plus a panel discussion and are designed to be interactive. Areas specifically covered will be diseases, general science issues (Big Data, genomics, clinical trials etcetera) and a focus on the views, progress and health landscapes in various Member States.

With involvement from policymakers/regulators, MEPs, national healthcare officials, patient groups, HTA bodies, academics, researchers, healthcare professionals, industry representatives, journalists and more, the aim is to shape the EU health landscape now and into the future.

Recommendations emerging from the Congress will look to steer policy and relevant legislation.